Pregled bibliografske jedinice broj: 1261382
CAVEOLIN-1 in prostate cancer
CAVEOLIN-1 in prostate cancer // HDBMB 2022: book of abstracts / Dulić, Morana ; Sinčić, Nino ; Vrhovac Madunić, Ivana (ur.).
Zagreb: Hrvatsko Društvo za Biotehnologiju, 2022. str. 152-152 (poster, domaća recenzija, sažetak, stručni)
CROSBI ID: 1261382 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
CAVEOLIN-1 in prostate cancer
Autori
Škara, Lucija ; Abramović, Irena ; Vrhovec, Borna ; Pezelj, Ivan ; Sinčić, Nino ; Tomas, Davor ; Ulamec, Monika
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
HDBMB 2022: book of abstracts
/ Dulić, Morana ; Sinčić, Nino ; Vrhovac Madunić, Ivana - Zagreb : Hrvatsko Društvo za Biotehnologiju, 2022, 152-152
Skup
Congress of the Croatian Society of Biochemistry and Molecular Biology with international participation
Mjesto i datum
Brela, Hrvatska, 28.09.2022. - 01.10.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
Caveolin-1 ; prostate cancer ; biomarkers ; seminal plasma
Sažetak
High prevalence and mortality of prostate cancer (PCa) is well known global health issue. Ongoing search upon new diagnostic, prognostic and predictive marker is always current. There is need of markers which could identify patients with PCa against benign conditions like prostate hyperplasia (BPH) or inflammation. Another issue dealing with indolent PCa course against aggressive forms of the disease is also topic of the intense research. CAV1 is protein whose expression differs among various cancer types and exhibits the dual role of this protein, acting as tumor promoter and tumor suppressor in different tumor settings. We estimated CAV1 could improve PCa diagnostics and aim of this study was to explore CAV1 methylation of cfDNA in liquid biopsy samples, blood and semen, as potential minimally invasive marker. In our study eighty patients with PCa and BPH were analyzed for CAV1 gene expression and methylation in tissue. CAV1 cfDNA methylation from blood and seminal plasma was accessed as potential PCa biomarker. Protein expression of CAV1 in tissue showed changed pattern in the PCa tissue. Methylation in seminal plasma showed potential as biomarker. Discrimination of BPH and Gleason grade group 1 PCa patients from patients with higher Gleason grade groups revealed very good performance as well. Based on our results CAV1 methylation may be useful biomarker with potential for further seminal plasma cfDNA research but its diagnostic accuracy should be improved.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
--UIP-2017-05-8138 - Epigenetički biomarkeri raka prostate (epiPro) (Sinčić, Nino) ( CroRIS)
--KK.01.1.1.01.0008 - Znanstveni centar izvrsnosti za reproduktivnu i regenerativnu medicinu – istraživanja novih platormi i potencijala (CERRM) (Ježek, Davor; Vukičević, Slobodan) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice"
Profili:
Monika Ulamec
(autor)
Borna Vrhovec
(autor)
Nino Sinčić
(autor)
Irena Abramović
(autor)
Davor Tomas
(autor)
Lucija Škara
(autor)